Kamagra Oral Jelly 100mg UK is used to get rid of the menace of Erectile Dysfunction to the core. This cheap online jelly is very safe to buy and you can avail great discounts and attractive offers on your exclusive purchase.
Over the last few years, we've seen the aftermath of Covid-19, with the demand for consumer health products being unprecedented and unpredictable, placing
pressure on supply chains and labour market. In turn, the industry has experienced acute shortages across the healthcare sector, placing huge pressure on
pharmacists, doctors, nurses, and other healthcare professionals.
Europe has an estimated shortage of around 50,000 public-sector doctors[1], which is set to increase in the coming years. While this shortage stems from several
complex problems, there is a hidden force that could play a key part in helping to alleviate this burden. That force is the potential of self-care.
Encouragingly, last month the UK government recognised the unique role that self-care can play through the introduction of its Delivery plan for recovering access
to primary care. Through this, it has pledged to empower patients to manage their own health through several commitments, including improving accessibility to
online tools and reclassifying medicines to make formerly prescribed options available over the counter.
Pharma giant, Pfizer has announced plans to cut 500 jobs at its Sandwich site in Kent, England as part of its ongoing $3.5 billion cost-cutting drive.
The company is also planning to shut its Pharmaceutical Sciences Small Molecule (PSSM) capabilities at the site, a spokesperson of the company told FiercePharma.
However, the Sandwich site will remain open and other functions will continue with "a different size," the spokesperson added.
Currently, around 940 people are employed at the site, which is the location where Pfizer scientists first discovered Viagra.
"We are proud of our heritage of breakthrough science in the UK and we will retain a scientific presence in the U.K. including at our Discovery Park location
in Sandwich," Pfizer's spokesperson confirmed in an email to FiercePharma.
Health leaders have said that delivering faster and more productive patient care would be difficult unless NHS capital budgets are nearly doubled to
at least £14.1 billion from the current spending of £7.7 billion.
The NHS Confederation has highlighted the impact that low levels of capital investment have had over the last decade in its report published today (29 November).
The report, 'Investing to save: The capital requirement for a more sustainable NHS in England', revealed that the UK has lagged behind other comparable countries
in terms of health capital investment for more than five decades, resulting in less productivity.
It revealed that the NHS now has the sixth lowest number of CT and MRI scanners per million people of the OECD countries.
The Royal College of Nursing (RCN) has expressed "extreme disappointment" that the UK government offered new pay to NHS consultants, while nursing pay deal
remain disputed.
RCN General Secretary and Chief Executive Pat Cullen has written to new Health Secretary Victoria Atkins demanding fresh negotiations regarding this year's pay
deal, and requested an urgent meeting to discuss their dispute.
Pat warned that more than 100,000 RCN members in England voted for continued strike action in June, as they feel undervalued.
"The government has now shown it has the political will to negotiate on pay reform for some of the highest earners in the NHS in contrast to our members who
received the lowest pay rise in the public sector," she wrote in the letter.
NHS nursing staff in England was awarded a five per cent pay rise 2023/24, but the union argued that it is not enough to keep up with inflation.
The Department of Health and Social Care (DHSC) on Thursday (30th November) announced the launch of a new suicide surveillance system, bolstering its
efforts to tackle emerging methods of suicide and clamp down on those seeking to sell dangerous products to vulnerable people.
For now, the DHSC will work with the National Police Chiefs' Council to gather near to real-time data from across the country on deaths by suspected suicide
by gender, age group and method.
The data will be obtained from individual police forces in England and the government will get it within three months of a suspected suicide, the DHSC said in
its release.
Previously, the only suicide data available at a national level was provided by the Office for National Statistics (ONS), but it could take up to 2 years for
the official ONS data to come through.
The MHRA's Criminal Enforcement Unit (CEU), working with other law enforcement partners, has seized more than two million "illegally traded medicines" this
year, with a total value of £5 million.
The products confiscated in the UK were prescription-only medicines including anti-depressants, pain medication and human growth hormones.
The MHRA launched an initiative, Operation Pangea, 15 years ago to combat "illegal internet trade in medical" products.
Andy Morling, the Deputy Director of Criminal Enforcement of MHRA, spoke about Operation Pangea's 15-year anniversary.
"Fifteen years ago, the MHRA started Operation Pangea, combining our knowledge and resources with those of international partners to disrupt and bring to justice
the criminal gangs responsible for selling medicines illegally and causing harm around the world.
Travelling with medical cannabis can be a complex and often confusing experience, given the diverse legal regulations across different countries and states.
Patients who rely on medical cannabis for their wellbeing need to be well-informed and prepared to ensure a smooth and hassle-free travel experience. This
comprehensive guide covers essential aspects, legal considerations, and practical tips for individuals who use medical cannabis and wish to travel.
Know the Laws
The first and most crucial step before travelling with medical cannabis is to understand the laws and regulations of both the departure and destination locations.
Laws regarding medical cannabis use vary significantly from one country, state, or even city to another. Some places have legalised medical cannabis, while others
strictly prohibit its use. Researching and familiarising oneself with the specific regulations of the destination, transit countries, and the home country is
essential.
Travelling Within the Same Country
When travelling within a country where medical cannabis is legal, patients generally need to carry their prescription information issued by a licensed healthcare
provider. It's advisable to keep medical cannabis in its original packaging, clearly labelled with the patient's name, prescribing physician, and dosage instructions.
Carrying a copy of the relevant laws and regulations can also be helpful in case of any inquiries from authorities. What can be easier than carrying around paperwork,
which could get easily damaged or lost during your travels, is to get a medical card that has a unique QR code on it from Releaf Cannabis, which, when scanned, can
present their prescription information digitally - it has revolutionised the way patients manage their healthcare. This eliminates the need for physical documents
and streamlines the process but also ensures the security and confidentiality of sensitive medical information, offering patients a more efficient and organi
The UK Health Security Agency (UKHSA) has published the latest national surveillance data on antibiotic prescribing and resistance.
The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report showed an increase in antibiotic use in all settings
(apart from dental) in 2022.
According to the report, antibiotic prescribing rose by 8.4 per cent in 2022 compared with 2021, although the number remains below 2019 pre-pandemic levels.
"There are many reasons behind the increase in prescribing, one of which is likely related to decreased immunity and exposure to infections during the
COVID-19 pandemic that may have underpinned the increased transmission in co-circulating infections, namely: influenza (flu), respiratory syncytial virus
(RSV) and group A streptococcus (GAS)," the report stated.
The Medicines and Healthcare products Regulatory Agency (MHRA) has cautioned people to stop using certain eye gels, highlighting a potential risk of
microbial contamination that can cause an infection.
As a precaution, the agency on Friday announced recall of specific batches of carbomer-containing lubricating eye gels branded Aacarb, Aacomer and Puroptics,
which are generally used to relieve the symptoms of dry eye.
Burkholderia cenocepacia is suspected to have caused the microbial contamination, and the issue was raised after an ongoing investigation conducted by UK Health
Security Agency (UKHSA) identified a small number of cases of infection.
Investigations are on to determine if there is a link between these products and the infections which have been identified.
Meanwhile, retailers have been told to withdraw the affected products, and users are asked to return their product to the place of purchase immediately.
A new study has revealed that the risk of death from COVID-19 decreases significantly after vaccination, but this protection diminishes after six months,
providing evidence for continued booster doses.
Researchers from the UK Health Security Agency (UKHSA), who analysed more than 10 million cases of COVID-19 in adults in England between May 2020 and February
2022, found a clear association between vaccination and reduced mortality.
But they also highlighted a crucial timeframe - within six months of the last vaccine dose - when Case Fatality Risk (CFR) - the proportion of cases that resulted
in death - was consistently at its lowest across all age groups. After this, the protective benefit of the vaccine began to wane and CFR increased.
The Department of Health and Social Care (DHSC) has published the full text of the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG).
The 2024 VPAG agreement text sets out the detailed terms of the agreement reached between DHSC, NHS England and the Association of the British Pharmaceutical
Industry (ABPI) to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.
The new voluntary scheme will come into force on 1 January 2024, following expiry of the 2019 Voluntary Scheme and shall remain in force for a period of five years,
until 31 December 2028.
Manufacturers or suppliers of branded medicines to the NHS have been given time till 15 January 2024 to decide whether to join the new 2024 Voluntary Scheme, or
default to the updated Statutory Scheme.
Global instant logistics leader, Zipline is partnering with UK drone delivery startup, Apian Aero to launch a drone delivery programme of critical medical
supplies for the Northumbria Healthcare NHS Foundation Trust.
The new service, expected to begin in the autumn of 2024, will see delivery of medical supplies to hospitals, GPs and care homes, using electric, autonomous drones.
Zipline announced the partnership on Sunday, and said drone delivery service will help provide timely access to prescription medicines, wound care products, joint
replacement implants, and other frequently ordered medical products, which could allow healthcare providers to reduce the number of cancelled procedures, and thus
decrease wait times.
Also, the expansion of the programme will help in creating local job opportunities in the region, it added.
The UK Health Security Agency (UKHSA) has raised alarm over rising cases of extensively antibiotic-resistant Shigella infections, mainly in gay, bisexual,
and other men who have physical relationship with men (GBMSM).
There has been a 53 per cent increase in cases since the beginning of 2023, mostly driven by a cluster of antibiotic resistant strain called Shigella sonnei,
with 97 cases reported this year until November, compared to just four cases last year.
According to UKHSA, Shigella sonnei infections are difficult to treat as the strain does not respond to the antibiotics typically used to treat the bacteria.
While it has been found across England, cases are concentrated in London (45), the North West (21) and South East (12).
Shigella is an infectious gut infection that can cause symptoms like diarrhoea (sometimes mixed with blood), stomach cramps and fever, which are commonly
mistaken for food poisoning.
The Medicines and Healthcare products Regulatory Agency (MHRA) made its new International Recognition procedure (IRP) fully operational from 1 January 2024,
inviting developers of new medicines to submit their applications for marketing authorisation.
Beginning this year, the EC Decision Reliance Procedure (ECDRP) has been replaced by IRP, and the Mutual Recognition/Decentralised Reliance Procedure (MRDCRP) has
come under its umbrella.
The move is expected to further improve access to life-saving medicines for UK patients following the UK's departure from the European Union.
The Medicines and Health products Regulatory Agency (MHRA) on Thursday issued a class 4 medicines defect information notice for Cozaar 100mg film-coated
tablets due to an error in the Patient Information Leaflets (PILs) reported by the company.
Cozaar is used to treat high blood pressure (hypertension) as well as to slow the progression of kidney disease in people who have type 2 diabetes mellitus.
Quadrant Pharmaceuticals Ltd has informed the UK regulatory authority that the PILs that have been packed in certain batches of the products do not have the most
up to date safety information.
'Grapefruit juice should be avoided while taking Cozaar'- This information is missing in Section 2 'What you need to know before you take Cozaar', sub section
'Cozaar with food and drink', the company clarified.
In a remarkable turn of events, the NHS App has emerged as a financial saviour for the National Health Service, slashing costs by over £1 million in the
last year alone.
The revelation comes as a testament to the app's growing significance in streamlining patient communication and service delivery.
Throughout the fiscal year 2023/24, a staggering 22.5 million messages traversed the NHS App, a feat previously reliant on traditional methods like text messages
or letters.
This monumental shift not only signifies a boon for efficiency but also heralds substantial savings, with each text message costing an average of 5p.
Drastically reducing these expenses has amounted to a commendable £1.1 million in savings, marking a pivotal milestone in NHS expenditure management.